About this document

cfDNA in Pleural Lavage for NSCLC Prognosis by rpbjrhj288 is a document available to read on EtoBox.

This pilot study investigates the feasibility of using cell-free DNA (cfDNA) in pleural lavage fluid as a predictive and prognostic biomarker for patients with surgically treated Stage I-III nonsmall cell lung cancer (NSCLC). The results indicate that cfDNA can be successfully isolated from pleural lavage and correlates with overall survival and disease-free survival, with higher levels associated with poorer outcomes. The study suggests that cfDNA in pleural lavage may serve as an important biomarker for a

Author

rpbjrhj288

Language

EN